Jarisch-Herxheimer reaction among HIV-positive patients with early syphilis: Azithromycin versus benzathine penicillin G therapy

Journal of the International AIDS Society

Volumn 17, Issue , 2014, Pages

  Tsai, Mao Song ^a   Yang, Chia Jui ^a   Lee, Nan Yao ^b   Hsieh, Szu Min ^c   Lin, Yu Hui ^d   Sun, Hsin Yun ^c   Sheng, Wang Huei ^c   Lee, Kuan Yeh ^c   Yang, Shan Ping ^c   Liu, Wen Chun ^c   Wu, Pei Ying ^c   Ko, Wen Chien ^b   Hung, Chien Ching ^c,e,f  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Immunomodulation; Macrolide resistance; Macrolides; Sexually transmitted diseases; Spirochetal disease

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIPYRETIC AGENT; AZITHROMYCIN; BACTERIAL DNA; BACTERIAL RNA; BENZATHINE PENICILLIN; REAGINIC ANTIBODY; RNA 23S; VIRUS RNA; ANTIINFECTIVE AGENT; RIBOSOME DNA;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIBODY BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIUM DETECTION; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DOSE RESPONSE; DRUG FEVER; FEMALE; GEL ELECTROPHORESIS; GENETIC ASSOCIATION; GENETIC RESISTANCE; HERXHEIMER REACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE DRUG DOSE; SYPHILIS; TREPONEMA PALLIDUM; CHEMICALLY INDUCED; CHEMISTRY; CLASSIFICATION; COHORT ANALYSIS; COMPARATIVE STUDY; COMPLICATION; DRUG EFFECTS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEVER; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROBIAL SENSITIVITY TEST; TAIWAN;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; COHORT STUDIES; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; FEVER; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; PENICILLIN G BENZATHINE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSPECTIVE STUDIES; RNA, RIBOSOMAL, 23S; SYPHILIS; TAIWAN; TREPONEMA PALLIDUM;

EID: 84907384197     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.17.1.18993     Document Type: Article

References (46)

1. Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010;59:1-110.
2. Riedner G, Rusizoka M, Todd J, Maboko L, Hoelscher M, Mmbando D, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med. 2005;353:1236-44. (Pubitemid 41345945)
3. Hook EW, 3rd, Behets F, Van Damme K, Ravelomanana N, Leone P, Sena AC, et al. A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. J Infect Dis. 2010;201:1729-35.
4. Mitchell SJ, Engelman J, Kent CK, Lukehart SA, Godornes C, Klausner JD. Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004. Clin Infect Dis. 2006;42:337-45. (Pubitemid 43122308)
5. Pound MW, May DB. Proposed mechanisms and preventative options of Jarisch-Herxheimer reactions. J Clin Pharm Ther. 2005;30:291-5. (Pubitemid 41603054)
6. Davis LE, Oyer R, Beckham JD, Tyler KL. Elevated CSF cytokines in the Jarisch-Herxheimer reaction of general paresis. JAMA Neurol. 2013;70:1060-4.
7. Silberstein P, Lawrence R, Pryor D, Shnier R. A case of neurosyphilis with a florid Jarisch-Herxheimer reaction. J Clin Neurosci. 2002;9:689-90. (Pubitemid 35364747)
8. Rustenhoven-Spaan I, Melkert P, Nelissen E, van Roosmalen J, Stekelenburg J. Maternal mortality in a rural Tanzanian hospital: fatal Jarisch-Herxheimer reaction in a case of relapsing fever in pregnancy. Trop Doct. 2013;43:138-41.
9. Emmanouilides CE, Kohn OF, Garibaldi R. Leptospirosis complicated by a Jarisch-Herxheimer reaction and adult respiratory distress syndrome: case report. Clin Infect Dis. 1994;18:1004-6. (Pubitemid 24171355)
10. Vaughan C, Cronin CC, Walsh EK, Whelton M. The Jarisch-Herxheimer reaction in leptospirosis. Postgrad Med J. 1994;70:118-21. (Pubitemid 24074633)
11. Maloy AL, Black RD, Segurola RJ, Jr. Lyme disease complicated by the Jarisch-Herxheimer reaction. J Emerg Med. 1998;16:437-8. (Pubitemid 28232710)
12. Dworkin MS, Anderson DE, Jr, Schwan TG, Shoemaker PC, Banerjee SN, Kassen BO, et al. Tick-borne relapsing fever in the northwestern United States and southwestern Canada. Clin Infect Dis. 1998;26:122-31. (Pubitemid 28068165)
13. Farmer TW. Jarisch-Herxheimer reaction in early syphilis treated with crystalline penicillin G. J Am Med Assoc. 1948;138:480-5.
14. Sheldon WH, Heyman A. Morphologic changes in syphilitic lesions during the Jarisch-Herxheimer reaction. Am J Syph Gonorrhea Vener Dis. 1949;33:213-24.
15. Miller WM, Gorini F, Botelho G, Moreira C, Barbosa AP, Pinto AR, et al. Jarisch-Herxheimer reaction among syphilis patients in Rio de Janeiro, Brazil. Int J STD AIDS. 2010;21:806-9.
16. Yang CJ, Lee NY, Lin YH, Lee HC, Ko WC, Liao CH, et al. Jarisch-Herxheimer reaction after penicillin therapy among patients with syphilis in the era of the HIV infection epidemic: incidence and risk factors. Clin Infect Dis. 2010;51:976-9.
17. Myles TD, Elam G, Park-Hwang E, Nguyen T. The Jarisch-Herxheimer reaction and fetal monitoring changes in pregnant women treated for syphilis. Obstet Gynecol. 1998;92:859-64. (Pubitemid 28487689)
18. Sheffield JS, Sánchez PJ, Morris G, Maberry M, Zeray F, McIntire DD, et al. Congenital syphilis after maternal treatment for syphilis during pregnancy. Am J Obstet Gynecol. 2002;186:569-73. (Pubitemid 34234175)
19. Zhou P, Qian Y, Xu J, Gu Z, Liao K. Occurrence of congenital syphilis after maternal treatment with azithromycin during pregnancy. Sex Transm Dis. 2007;34:472-4. (Pubitemid 46987953)
20. Griffin GE. Cytokines involved in human septic shock-the model of the Jarisch-Herxheimer reaction. J Antimicrob Chemother. 1998;41 Suppl A:25-9.
21. Fekade D, Knox K, Hussein K, Melka A, Lalloo DG, Coxon RE, et al. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. N Engl J Med. 1996;335:311-5. (Pubitemid 26362378)
22. Coxon RE, Fekade D, Knox K, Hussein K, Melka A, Daniel A, et al. The effect of antibody against TNF alpha on cytokine response in Jarisch-Herxheimer reactions of louse-borne relapsing fever. QJM. 1997;90:213-21. (Pubitemid 27122560)
23. Teklu B, Habte-Michael A, Warrell DA, White NJ, Wright DJ. Meptazinol diminishes the Jarisch-Herxheimer reaction of relapsing fever. Lancet. 1983;1:835-9. (Pubitemid 13165289)
24. Cooper PJ, Fekade D, Remick DG, Grint P, Wherry J, Griffin GE. Recombinant human interleukin-10 fails to alter proinflammatory cytokine production or physiologic changes associated with the Jarisch-Herxheimer reaction. J Infect Dis. 2000;181:203-9. (Pubitemid 30049050)
25. Remick DG, Negussie Y, Fekade D, Griffin G. Pentoxifylline fails to prevent the Jarisch-Herxheimer reaction or associated cytokine release. J Infect Dis. 1996;174:627-30. (Pubitemid 26299701)
26. Butler T, Jones PK, Wallace CK. Borrelia recurrentis infection: single-dose antibiotic regimens and management of the Jarisch-Herxheimer reaction. J Infect Dis. 1978;137:573-7. (Pubitemid 8331814)
27. Schentag JJ, Ballow CH. Tissue-directed pharmacokinetics. Am J Med. 1991;91:5S-11S.
28. Giamarellos-Bourboulis EJ. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators. Int J Antimicrob Agents. 2008;31:12-20. (Pubitemid 350236720)
29. Ivetić Tkalcević V, Bosnjak B, Hrvacić B, Bosnar M, Marjanović N, Ferencić Z, et al. Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice. Eur J Pharmacol. 2006;539:131-8. (Pubitemid 44208808)
30. Wu H, Chang SY, Lee NY, Huang WC, Wu BR, Yang CJ, et al. Evaluation of macrolide resistance and enhanced molecular typing of Treponema pallidum in patients with syphilis in Taiwan: a prospective multicenter study. J Clin Microbiol. 2012;50:2299-304.
31. Wu BR, Yang CJ, Tsai MS, Lee KY, Lee NY, Huang WC, et al. Multicentre surveillance of prevalence of the 23S rRNA A2058G and A2059G point mutations and molecular subtypes of Treponema pallidum in Taiwan, 2009-2013. Clin Microbiol Infect. 2014. DOI: 10.1111/1469-0691.12529. [Epub ahead of print]
32. Liu H, Rodes B, Chen CY, Steiner B. New tests for syphilis: rational design of a PCR method for detection of Treponema pallidum in clinical specimens using unique regions of the DNA polymerase I gene. J Clin Microbiol. 2001;39:1941-6. (Pubitemid 32417048)
33. Matejková P, Flasarová M, Zákoucká H, Borek M, Kremenová S, Arenberger P, et al. Macrolide treatment failure in a case of secondary syphilis: a novel A2059G mutation in the 23S rRNA gene of Treponema pallidum subsp. Pallidum. J Med Microbiol. 2009;58:832-6.
34. Chen CY, Chi KH, Pillay A, Nachamkin E, Su JR, Ballard RC. Detection of the A2058G and A2059G 23S rRNA gene point mutations associated with azithromycin resistance in Treponema pallidum by use of a TaqMan real-time multiplex PCR assay. J Clin Microbiol. 2013;51:908-13.
35. Lukehart SA, Godornes C, Molini BJ, Sonnett P, Hopkins S, Mulcahy F, et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med. 2004;351:154-8.
36. See S, Scott EK, Levin MW. Penicillin-induced Jarisch-Herxheimer reaction. Ann Pharmacother. 2005;39:2128-30. (Pubitemid 41745963)
37. Lukehart SA, Fohn MJ, Baker-Zander SA. Efficacy of azithromycin for therapy of active syphilis in the rabbit model. J Antimicrob Chemother. 1990;25(Suppl A):91-9. (Pubitemid 20043954)
38. Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. Eur J Clin Pharmacol. 2012;68:479-503.
39. Srivastava P, Bhengraj AR, Jha HC, Vardhan H, Jha R, Singh LC, et al. Differing effects of azithromycin and doxycycline on cytokines in cells from Chlamydia trachomatis-infected women. DNA Cell Biol. 2012;31:392-401.
40. Chen XS, Yin YP, Wei WH, Wang HC, Peng RR, Zheng HP, et al. High prevalence of azithromycin resistance to Treponema pallidum in geographically different areas in China. Clin Microbiol Infect. 2013;19:975-9.
41. Muller EE, Paz-Bailey G, Lewis DA. Macrolide resistance testing and molecular subtyping of Treponema pallidum strains from southern Africa. Sex Transm Infect. 2012;88:470-4.
42. Grimes M, Sahi SK, Godornes BC, Tantalo LC, Roberts N, Bostick D, et al. Two mutations associated with macrolide resistance in Treponema pallidum: increasing prevalence and correlation with molecular strain type in Seattle, Washington. Sex Transm Dis. 2012;39:954-8.
43. Muldoon EG, Walsh A, Crowley B, Mulcahy F. Treponema pallidum azithromycin resistance in Dublin, Ireland. Sex Transm Dis. 2012;39:784-6.
44. A2058G Prevalence Workgroup. Prevalence of the 23S rRNA A2058G point mutation and molecular subtypes in Treponema pallidum in the United States, 2007 to 2009. Sex Transm Dis. 2012;39:794-8.
45. Seña AC, Wolff M, Martin DH, Behets F, Van Damme K, Leone P, et al. Predictors of serological cure and Serofast State after treatment in HIV-negative persons with early syphilis. Clin Infect Dis. 2011;53:1092-9.
46. Rompalo AM, Cannon RO, Quinn TC, Hook EW, 3rd. Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection. J Infect Dis. 1992;165:1124-6.